High Court Seeks Lamictal Buyers' Views On Antitrust Appeal

The U.S. Supreme Court has asked purchasers of the anticonvulsant Lamictal to respond to GlaxoSmithKline's and Teva's argument that the justices should review a Third Circuit decision allowing the drug buyers...

Already a subscriber? Click here to view full article